Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Edgewise Therapeutics, Inc. (EWTX)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 92,270,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of treatments for severe, rare muscle disorders. Co.'s primary product candidate, EDG-5506, is an orally administered allosteric, selective, fast myofiber (type II) myosin small molecule inhibitor designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. Using its proprietary drug discovery platform, Co. is developing a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address a range of genetically defined muscle disorders.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 919,947 919,947 2,649,435
Total Buy Value $0 $10,100,948 $10,100,948 $27,090,905
Total People Bought 0 3 3 4
Total Buy Transactions 0 3 3 8
Total Shares Sold 39,835 310,917 323,956 531,581
Total Sell Value $797,064 $3,916,139 $4,032,251 $5,469,583
Total People Sold 2 4 6 6
Total Sell Transactions 6 9 15 33
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 117
  Page 1 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Moore John R General Counsel   •       –      –    2024-02-09 4 AS $20.01 $160,657 D/D (8,029) 0     -
   Moore John R General Counsel   •       –      –    2024-02-09 4 OE $1.93 $15,496 D/D 8,029 8,029     -
   Derakhshan Behrad Chief Business Officer   •       –      –    2024-02-09 4 AS $20.04 $96,209 D/D (4,800) 7,020     -
   Derakhshan Behrad Chief Business Officer   •       –      –    2024-02-09 4 OE $1.93 $9,264 D/D 4,800 11,820     -
   Moore John R General Counsel   •       –      –    2024-02-08 4 AS $20.01 $76,285 D/D (3,813) 0     -
   Moore John R General Counsel   •       –      –    2024-02-08 4 OE $1.93 $7,359 D/D 3,813 3,813     -
   Derakhshan Behrad Chief Business Officer   •       –      –    2024-02-08 4 AS $20.01 $92,049 D/D (4,600) 7,020     -
   Derakhshan Behrad Chief Business Officer   •       –      –    2024-02-08 4 OE $1.93 $8,878 D/D 4,600 11,620     -
   Moore John R General Counsel   •       –      –    2024-02-07 4 AS $20.00 $359,864 D/D (17,993) 0     -
   Moore John R General Counsel   •       –      –    2024-02-07 4 OE $1.93 $34,726 D/D 17,993 17,993     -
   Derakhshan Behrad Chief Business Officer   •       –      –    2024-02-07 4 AS $20.00 $12,000 D/D (600) 7,020     -
   Derakhshan Behrad Chief Business Officer   •       –      –    2024-02-07 4 OE $1.93 $1,158 D/D 600 7,620     -
   Carruthers R Michael Chief Financial Officer   •       –      –    2024-01-23 4 AS $15.78 $1,419,759 D/D (90,000) 29,024     -
   Carruthers R Michael Chief Financial Officer   •       –      –    2024-01-23 4 OE $1.93 $173,700 D/D 90,000 119,024     -
   Thompson Peter A Director   –       •       •   2024-01-23 4 B $11.00 $4,999,995 I/I 454,545 14,436,497 2.25     -
   Orbimed Genesis Gp Llc Director   –       •       •   2024-01-23 4 B $11.00 $4,999,995 I/I 454,545 14,436,497 2.25     -
   Moore John R General Counsel   •       –      –    2023-12-27 4 AS $10.50 $89,219 D/D (8,497) 0     -
   Russell Alan J Chief Scientific Officer   •       •      –    2023-12-26 4 S $9.33 $1,610,097 D/D (172,585) 3,606     -
   Fox Jonathan C   –       •      –    2023-12-26 4 B $9.30 $100,958 D/D 10,857 10,857 0.01     -
   Carruthers R Michael Chief Financial Officer   •       –      –    2023-06-22 4 OE $0.71 $7,100 D/D 10,000 29,024     -
   Koch Kevin President and CEO   •       •      –    2023-05-02 4 S $8.90 $28,522 D/D (3,203) 7,213     -
   Moore John R General Counsel   •       –      –    2023-05-02 4 S $8.90 $16,893 D/D (1,897) 6,565     -
   Donovan Joanne M. CMO   •       –      –    2023-05-02 4 S $8.90 $28,977 D/D (3,254) 9,960     -
   Russell Alan J Chief Scientific Officer   •       •      –    2023-05-02 4 S $8.90 $14,266 D/D (1,602) 176,191     -
   Carruthers R Michael Chief Financial Officer   •       –      –    2023-05-02 4 S $8.90 $11,897 D/D (1,336) 16,126     -
  117 Records found
  1  2  3  4  5   
  Page 1 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us